| Product Code: ETC9560570 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Sweden Non-24-Hour Sleep-Wake Disorder Drug Market Overview |
3.1 Sweden Country Macro Economic Indicators |
3.2 Sweden Non-24-Hour Sleep-Wake Disorder Drug Market Revenues & Volume, 2021 & 2031F |
3.3 Sweden Non-24-Hour Sleep-Wake Disorder Drug Market - Industry Life Cycle |
3.4 Sweden Non-24-Hour Sleep-Wake Disorder Drug Market - Porter's Five Forces |
3.5 Sweden Non-24-Hour Sleep-Wake Disorder Drug Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.6 Sweden Non-24-Hour Sleep-Wake Disorder Drug Market Revenues & Volume Share, By Treatment Type, 2021 & 2031F |
3.7 Sweden Non-24-Hour Sleep-Wake Disorder Drug Market Revenues & Volume Share, By Drugs, 2021 & 2031F |
3.8 Sweden Non-24-Hour Sleep-Wake Disorder Drug Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.9 Sweden Non-24-Hour Sleep-Wake Disorder Drug Market Revenues & Volume Share, By End Users, 2021 & 2031F |
3.10 Sweden Non-24-Hour Sleep-Wake Disorder Drug Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Sweden Non-24-Hour Sleep-Wake Disorder Drug Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness and diagnosis of non-24-hour sleep-wake disorders in Sweden |
4.2.2 Growing research and development initiatives focused on developing innovative drugs for treating non-24-hour sleep-wake disorders |
4.2.3 Rising prevalence of lifestyle factors leading to sleep disorders in the Swedish population |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for drug approval in Sweden |
4.3.2 High costs associated with the development and commercialization of drugs for non-24-hour sleep-wake disorders |
4.3.3 Limited availability of healthcare professionals specialized in diagnosing and treating non-24-hour sleep-wake disorders in Sweden |
5 Sweden Non-24-Hour Sleep-Wake Disorder Drug Market Trends |
6 Sweden Non-24-Hour Sleep-Wake Disorder Drug Market, By Types |
6.1 Sweden Non-24-Hour Sleep-Wake Disorder Drug Market, By Indication |
6.1.1 Overview and Analysis |
6.1.2 Sweden Non-24-Hour Sleep-Wake Disorder Drug Market Revenues & Volume, By Indication, 2021- 2031F |
6.1.3 Sweden Non-24-Hour Sleep-Wake Disorder Drug Market Revenues & Volume, By Circadian Rhythm Sleep Disorder, 2021- 2031F |
6.1.4 Sweden Non-24-Hour Sleep-Wake Disorder Drug Market Revenues & Volume, By Hypernychthemeral Syndrome, 2021- 2031F |
6.1.5 Sweden Non-24-Hour Sleep-Wake Disorder Drug Market Revenues & Volume, By Shift Work Disorder, 2021- 2031F |
6.1.6 Sweden Non-24-Hour Sleep-Wake Disorder Drug Market Revenues & Volume, By Jet Lag and Others, 2021- 2031F |
6.2 Sweden Non-24-Hour Sleep-Wake Disorder Drug Market, By Treatment Type |
6.2.1 Overview and Analysis |
6.2.2 Sweden Non-24-Hour Sleep-Wake Disorder Drug Market Revenues & Volume, By Therapeutic Devices, 2021- 2031F |
6.2.3 Sweden Non-24-Hour Sleep-Wake Disorder Drug Market Revenues & Volume, By Drugs, 2021- 2031F |
6.2.4 Sweden Non-24-Hour Sleep-Wake Disorder Drug Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Sweden Non-24-Hour Sleep-Wake Disorder Drug Market, By Drugs |
6.3.1 Overview and Analysis |
6.3.2 Sweden Non-24-Hour Sleep-Wake Disorder Drug Market Revenues & Volume, By Nonbenzodiazepines, 2021- 2031F |
6.3.3 Sweden Non-24-Hour Sleep-Wake Disorder Drug Market Revenues & Volume, By Benzodiazepines, 2021- 2031F |
6.3.4 Sweden Non-24-Hour Sleep-Wake Disorder Drug Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Sweden Non-24-Hour Sleep-Wake Disorder Drug Market, By Route of Administration |
6.4.1 Overview and Analysis |
6.4.2 Sweden Non-24-Hour Sleep-Wake Disorder Drug Market Revenues & Volume, By Oral, 2021- 2031F |
6.4.3 Sweden Non-24-Hour Sleep-Wake Disorder Drug Market Revenues & Volume, By Injectable, 2021- 2031F |
6.4.4 Sweden Non-24-Hour Sleep-Wake Disorder Drug Market Revenues & Volume, By Others, 2021- 2031F |
6.5 Sweden Non-24-Hour Sleep-Wake Disorder Drug Market, By End Users |
6.5.1 Overview and Analysis |
6.5.2 Sweden Non-24-Hour Sleep-Wake Disorder Drug Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.5.3 Sweden Non-24-Hour Sleep-Wake Disorder Drug Market Revenues & Volume, By Home Care Settings, 2021- 2031F |
6.5.4 Sweden Non-24-Hour Sleep-Wake Disorder Drug Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.5.5 Sweden Non-24-Hour Sleep-Wake Disorder Drug Market Revenues & Volume, By Wellness Centers and Spa, 2021- 2031F |
6.5.6 Sweden Non-24-Hour Sleep-Wake Disorder Drug Market Revenues & Volume, By Others, 2021- 2031F |
6.6 Sweden Non-24-Hour Sleep-Wake Disorder Drug Market, By Distribution Channel |
6.6.1 Overview and Analysis |
6.6.2 Sweden Non-24-Hour Sleep-Wake Disorder Drug Market Revenues & Volume, By Retail Pharmacies, 2021- 2031F |
6.6.3 Sweden Non-24-Hour Sleep-Wake Disorder Drug Market Revenues & Volume, By Drug Stores, 2021- 2031F |
6.6.4 Sweden Non-24-Hour Sleep-Wake Disorder Drug Market Revenues & Volume, By Online Pharmacies, 2021- 2031F |
6.6.5 Sweden Non-24-Hour Sleep-Wake Disorder Drug Market Revenues & Volume, By Others, 2021- 2031F |
7 Sweden Non-24-Hour Sleep-Wake Disorder Drug Market Import-Export Trade Statistics |
7.1 Sweden Non-24-Hour Sleep-Wake Disorder Drug Market Export to Major Countries |
7.2 Sweden Non-24-Hour Sleep-Wake Disorder Drug Market Imports from Major Countries |
8 Sweden Non-24-Hour Sleep-Wake Disorder Drug Market Key Performance Indicators |
8.1 Patient adherence rates to prescribed non-24-hour sleep-wake disorder drugs |
8.2 Number of clinical trials conducted for new drugs targeting non-24-hour sleep-wake disorders |
8.3 Average time taken for drug approval by regulatory authorities in Sweden |
9 Sweden Non-24-Hour Sleep-Wake Disorder Drug Market - Opportunity Assessment |
9.1 Sweden Non-24-Hour Sleep-Wake Disorder Drug Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.2 Sweden Non-24-Hour Sleep-Wake Disorder Drug Market Opportunity Assessment, By Treatment Type, 2021 & 2031F |
9.3 Sweden Non-24-Hour Sleep-Wake Disorder Drug Market Opportunity Assessment, By Drugs, 2021 & 2031F |
9.4 Sweden Non-24-Hour Sleep-Wake Disorder Drug Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.5 Sweden Non-24-Hour Sleep-Wake Disorder Drug Market Opportunity Assessment, By End Users, 2021 & 2031F |
9.6 Sweden Non-24-Hour Sleep-Wake Disorder Drug Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Sweden Non-24-Hour Sleep-Wake Disorder Drug Market - Competitive Landscape |
10.1 Sweden Non-24-Hour Sleep-Wake Disorder Drug Market Revenue Share, By Companies, 2024 |
10.2 Sweden Non-24-Hour Sleep-Wake Disorder Drug Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here